| Peter Zigfrid Zadvinskis, MD | |
|
3271 Clear Vista Ct Ne, Grand Rapids, MI 49525-9477 | |
| (616) 267-7293 | |
| (616) 267-9594 |
| Full Name | Peter Zigfrid Zadvinskis |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 34 Years |
| Location | 3271 Clear Vista Ct Ne, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043381353 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | PZ056351 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spectrum Health Reed City Hospital | Reed city, MI | Hospital |
| Spectrum Health United Hospital | Greenville, MI | Hospital |
| Munson Healthcare Cadillac Hospital | Cadillac, MI | Hospital |
| Spectrum Health Big Rapids Hospital | Big rapids, MI | Hospital |
| Spectrum Health | Grand rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Health Primary Care Partners | 4587568647 | 1585 |
News Archive
EpiCept Corporation today announced that Health Canada has accepted for review the Company's New Drug Submission (NDS) for Ceplene® (histamine dihydrochloride) for the remission maintenance of acute myeloid leukemia (AML) patients in first complete remission.
In a peer-reviewed published study, a new medically engineered pressure-technology disposable adhesive device (Pressure Right-) developed by Pressure Point Inc. has clinically proven to enhance the efficacy of a popular prophylactic antiemetic drug combination in reducing the incidence of postoperative nausea and vomiting (PONV) among high-risk patients after major laparoscopic surgery procedures.
Patients who experience abrupt kidney injury following surgery have an increased risk of later developing heart problems, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
In May 2013 Angelina Jolie, who was then Hollywood's highest-paid actress, underwent a double mastectomy after testing positive for a BRCA1 gene mutation that significantly increases the risk of developing breast cancer. A recent study, published by Breast Cancer Research has found that, public knowledge of her decision doubled NHS referrals for genetic testing for breast cancer risk.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.
› Verified 4 days ago
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
EpiCept Corporation today announced that Health Canada has accepted for review the Company's New Drug Submission (NDS) for Ceplene® (histamine dihydrochloride) for the remission maintenance of acute myeloid leukemia (AML) patients in first complete remission.
In a peer-reviewed published study, a new medically engineered pressure-technology disposable adhesive device (Pressure Right-) developed by Pressure Point Inc. has clinically proven to enhance the efficacy of a popular prophylactic antiemetic drug combination in reducing the incidence of postoperative nausea and vomiting (PONV) among high-risk patients after major laparoscopic surgery procedures.
Patients who experience abrupt kidney injury following surgery have an increased risk of later developing heart problems, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
In May 2013 Angelina Jolie, who was then Hollywood's highest-paid actress, underwent a double mastectomy after testing positive for a BRCA1 gene mutation that significantly increases the risk of developing breast cancer. A recent study, published by Breast Cancer Research has found that, public knowledge of her decision doubled NHS referrals for genetic testing for breast cancer risk.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Zigfrid Zadvinskis, MD 100 Michigan St Ne, Mc 845, Grand Rapids, MI 49503-2560 Ph: (616) 486-6790 | Peter Zigfrid Zadvinskis, MD 3271 Clear Vista Ct Ne, Grand Rapids, MI 49525-9477 Ph: (616) 267-7293 |
News Archive
EpiCept Corporation today announced that Health Canada has accepted for review the Company's New Drug Submission (NDS) for Ceplene® (histamine dihydrochloride) for the remission maintenance of acute myeloid leukemia (AML) patients in first complete remission.
In a peer-reviewed published study, a new medically engineered pressure-technology disposable adhesive device (Pressure Right-) developed by Pressure Point Inc. has clinically proven to enhance the efficacy of a popular prophylactic antiemetic drug combination in reducing the incidence of postoperative nausea and vomiting (PONV) among high-risk patients after major laparoscopic surgery procedures.
Patients who experience abrupt kidney injury following surgery have an increased risk of later developing heart problems, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
In May 2013 Angelina Jolie, who was then Hollywood's highest-paid actress, underwent a double mastectomy after testing positive for a BRCA1 gene mutation that significantly increases the risk of developing breast cancer. A recent study, published by Breast Cancer Research has found that, public knowledge of her decision doubled NHS referrals for genetic testing for breast cancer risk.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.
› Verified 4 days ago
Maureen U Tan- Pedres, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Suite A721, Grand Rapids, MI 49503 Phone: 616-391-3139 Fax: 616-391-3044 | |
Jeffery Allen Woo, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1900 Wealthy St Se, Ste 150, Grand Rapids, MI 49506 Phone: 616-459-3158 Fax: 616-988-0071 | |
Robert W Selfe, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 221 Michigan St Ne, Suite 200, Grand Rapids, MI 49503 Phone: 616-267-8950 Fax: 616-267-8585 | |
Dr. Erin Megan Pettijohn, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 250 Cherry St Se Ste 2200, Grand Rapids, MI 49503 Phone: 616-685-5600 | |
Dr. Andrew Leo Sochacki, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5800 Foremost Dr Se Ste 200, Grand Rapids, MI 49546 Phone: 616-389-1800 | |
Stephanie F Williams, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 145 Michigan St Ne, Suite 5200, Grand Rapids, MI 49503 Phone: 616-486-5933 Fax: 616-486-6489 | |
Simin Beg, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 145 Michigan St Ne Ste 3410, Grand Rapids, MI 49503 Phone: 616-391-9945 |